Sheron Perera - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sheron Perera

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Clinical Pathology|September 29, 2021

Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.

Nature Communications|July 2, 2025

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Clinical Pathology|September 29, 2021

Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literatureMichael J Allen, Amy Zhang, Prashant Bavi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022

hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal AdenocarcinomaSheron Perera, Gun Ho Jang, Yifan Wang, et al.

Nature Communications|July 2, 2025

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialJennifer J Knox, Gun Ho Jang, Robert C Grant, et al.

Pageof 2